VICKERS VENTURE PARTNERS

Thesis

Vickers Venture Partners is a global venture capital firm established in 2005, specializing in deep technology and life sciences. Their investment thesis centers on solving significant global challenges through technological innovation, with a strong commitment to Environmental, Social, and Governance (ESG) principles. The firm invests across multiple stages, from pre-seed to growth equity, with a notable focus on Series A and early-stage companies. Key sectors of interest include artificial intelligence, healthcare, biotechnology, renewable energy, synthetic biology, drug discovery, medical devices, and advanced manufacturing. Vickers' strategy involves identifying category-defining companies worldwide, leveraging a geographic focus that connects Singaporean innovation with Chinese market scale and US commercial validation. They prioritize visionary, resilient, and integrity-driven founders and actively seek technologies addressing critical global issues like plastic waste, human health, clean energy, and pandemics. A distinguishing factor of Vickers' approach is its tolerance for 'science risk' over execution risk, supporting entrepreneurs developing groundbreaking technologies for known problems with clear market needs. The firm manages over $3.2 billion in AUM and has a portfolio of approximately 230 companies, with a significant presence in the United States, China, and Singapore.

Related lists

• Pre-seed AI investors
• Pre-seed Healthcare investors
• Seed-stage AI investors